Moderna patented a 19-nucleotide sequence in 2013 that matches the most infectious sequence of SARS-CoV-2

In the quest to uncover the origins for SARS-CoV-2, scientists did not have to look very far. For years, the National Institutes of Health, in cooperation with EcoHealth Alliance and the University of North Carolina conducted gain-of-function research specifically on coronaviruses. Much of this controversial work was off-shored to the Wuhan Institute of Virology in China, due to moratoriums on gain-of-function virology research in the US.

Some of the most notorious authoritarians in public health (Anthony Fauci) were directly involved in funding and overseeing coronavirus research, so it’s rather suspicious, to say the least, that Fauci himself would denounce any laboratory origins of SARS-CoV-2 as “conspiracy theory” as early as March 2020. If anyone should be more transparent, it should be him.

Scientists also did not have to look far to find out that Moderna (one of the covid-19 vaccine profiteers) patented a 19-nucleotide sequence in 2013, that somehow, randomly appeared in the Furin cleavage site of the covid-19 spike protein.

Moderna has been preparing for covid-19 mRNA vaccine experiments for years

In the leadup to 2020, a little-known biotech company called Moderna was granted up to $100 million from the Bill and Melinda Gates Foundation to develop new vaccine candidates using mRNA technology. From this platform, Moderna received hundreds of millions of dollars in new investments and even secured $1 billion from taxpayers in 2020 (Operation Warp Speed) for research and development into a vaccine for covid-19.

As far back as 2013, Moderna had already filed for a coronavirus patent, containing a 19-nucleotide sequence. This precise nucleotide sequence randomly appeared in the Furin cleavage site of the covid-19 spike protein. The genetic sequences of this spike protein (the alleged causative agent for covid-19) were ultimately used as a basis to develop an experimental mRNA vaccine through none other than — Moderna. The technology was also shared with Pfizer; however, Moderna is currently initiating legal challenges to secure their property rights over their patents on the mRNA and the spike protein sequences. Eventually, Moderna would receive another $1.525 billion from taxpayers, in an agreement that would ship 100 million doses of its mRNA vaccine candidate to pharmacies nationwide.

Scientists link Moderna’s patents to the most pathogenic part of SARS-CoV-2

Scientists from India, Switzerland, Italy and the US published an important paper titled, “MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site.” The 19-nucleotide sequence (patented by Moderna) randomly appeared in the furin cleavage site of the spike protein (SARS-CoV-2). The scientists calculated the random chance of that happening as 1 in 3 trillion!

The scientists used the Basic Local Alignment Search Tool to search for the gene sequence, in a database that includes every gene sequence in nature known to man. They searched for the gene sequence, its reverse gene sequence and the complimentary gene sequence and its reverse sequence. They found the sequence in Moderna’s patents, in reverse compliment form: CTACGTGCCCGCCGAGGAG.

This precise gene letter sequence was the only nucleotide sequence in SARS-CoV-2 that had more than 3 nucleotides. Its closest natural relative was Bat Coronavirus RaTG13. It was included on the furin cleavage site, which is the part of the spike protein most associated with viral attachment and pathogenic potential. If the coronavirus spike protein was enhanced in a lab, then the furin cleavage site would be the best location to enhance its pathogenic potential. As the genetic evidence shows, Moderna was part of the planning and implementation of covid-19, gain-of-function experimentation, and vaccine profiteering.

Here are the patents:
US9149506B2: Modified polynucleotides encoding septin-4 – 2013-12-16 Application filed by Moderna Therapeutics Inc.
Inventor: Tirtha Chakraborty, Antonin de Fougerolles

US9216205B2: Modified polynucleotides encoding granulysin – 2013-12-16 Application filed by Moderna Therapeutics Inc.

US9255129B2: Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1 – 2013-12-16 Application filed by Moderna Therapeutics Inc.

US9301993B2: Modified polynucleotides encoding apoptosis inducing factor 1 – 2013-12-16 Application filed by Moderna Therapeutics Inc.

US9587003B2: Modified polynucleotides for the production of oncology-related proteins and peptides – 2016-02-04 Application filed by ModernaTx Inc.
Inventor: Stephane Bancel, Tirtha Chakraborty, Antonin de Fougerolles, Sayda M. Elbashir, Matthias John, Atanu Roy, Susan Whoriskey, Kristy M. Wood, Paul Hatala, Jason P. Schrum, Kenechi Ejebe, Jeff Lynn Ellsworth, Justin Guild

Learn more about this bombshell SARS-CoV-2 laboratory origin evidence at The Expose.

Sources include:

‘Child abuse’: Congressman demands NIH investigate transgender drugs, surgeries for minors

 Republican U.S. Rep. Paul Gosar last week urged that the National Institutes of Health (NIH) investigate the actual science behind so-called “Gender Affirming Care” for minors that involves the chemical and physical mutilation of children.

Gosar, who has represented Arizona’s fourth district since 2013 and is currently running for reelection, made the remarks in an October 21 letter addressed to NIH Acting Director Dr. Lawrence A. Tabak, D.D.S., Ph.D., and Dr. Karen Parker, Ph.D., M.S.W., who heads up the NIH’s Sexual & Gender Minority Research Office (SGMRO).

Noting that the SGMRO is slated to conduct a workshop to “identify and prioritize key infrastructure and research” to support “gender affirming care for transgender and gender diverse population,” Gosar urged the officials to look into existing research that he said debunks theories about the beneficial effects of surgical and pharmaceutical gender interventions.

New Swiss Study: Covid Shots Increase Risk of Myocarditis by 800 TIMES in Young Adults

The risk of myocarditis is 800 times higher for vaccinated than unvaccinated young adults, according to a recent Swiss study that is now gaining traction in the press.

The results were based on the presentation by Prof. Christian Mueller (Basel, Switzerland) at the European Society of Cardiology Congress in August 2022: “Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination.” According to the presentation at the conference:

  • Prior to this study, there were no prospective data on post-vaccination myocardial lesions during vaccination with an mRNA vaccine. Only the most serious hospitalized myocarditis have been reported, mainly affecting men under 18 years of age.
  • The actual incidence of post-vaccination myocardial lesions is 2.8% vs 0.0035% of myocarditis in retrospective studies
  • Myocardial lesions affect women more — contrary to what is described in previous studies.
  • The possibility of repeated doses of vaccine in order to maintain effective vaccination coverage should lead to great caution regarding possible repeated myocardial lesions and their impact on possible cardiovascular complications.

“We know that there are potentially serious side effects to the COVID 19 mRNA vaccine such as myocarditis,” the authors state. “In retrospective data, the main cardiac complication is myocarditis, which remains rare with an incidence of 0.0035% and mainly affects young men under 18 years of age.”

“However, there is a selection bias because only serious cases requiring hospitalization are reported,” the authors continue. “The true incidence of myocardial damage would therefore likely be much higher in the general population. Moreover, due to the need for repeated doses and the large number of people to be vaccinated, even this rare complication is not anecdotal.”

The researchers then reveal how they conducted their study.

“A total of 835 patients were included, including 777 who received troponinemia assay on D3, among these patients 40 had increased troponinemia,” the researchers note. “In 18 of them, causes other than the vaccine were identified that could explain the elevated troponinemia, and in the remaining 22 no cause other than the vaccine was implicated. The population studied was mainly composed of women (69%), the average age was 37 years and the patients overwhelmingly received their 3rd dose ( 92%). Less than 2% of them had a cardiovascular history.”

Dangerous new Covid strain created in Imperial College London Bio Weapons lab

Researchers at the Imperial College London have created a new strain of the Covid virus very similar to a variant manufactured at Boston University’s National Emerging Infectious Diseases Laboratories earlier this year, both institutions echoing experiments which many believe led to the Covid-19 pandemic.

According to the Daily Mail, like Boston University, Imperial College London created a mutant version of the virus by hybridizing the original Wuhan strain of the disease with either the Omicron or Delta variants, and then injecting the newly man-made virus into hamsters in a process that molecular biology expert Dr. Richard Ebright said had zero “foreseeable practical applications.”

“After Boston University created a new Covid with an 80 percent kill rate, it’s now been revealed Imperial College London has done nearly the same thing, merging the deadly original virus with the highly contagious Omicron,” said Charlie Kirk of the discovery.

Dr. Ebright, a specialist in molecular biology who develops drugs to treat infectious diseases, said the creation of new Covid “is insanity, both In terms of the redundancy and waste.”

Both Boston University and Imperial College London have received criticism for their mutated Covid work, as many in the medical community worry that marrying the more lethal characteristics of Wuhan Covid with a strain like Omicron, which is significantly more transmissible, could result in another worldwide catastrophic pandemic if the new  man-made disease ever escaped the lab.

The Boston University mutant Covid virus had an 80 percent kill rate in mice.

Imperial College London denied that their work was gain of function, which is defined as any experimentation that results in enhanced biological functions of a virus.

A former director of the Israeli Government’s Institute for Biological Research, Professor Shmuel Shapira, described the work these institutions are doing as “playing with fire.” Both experiments were conducted at biosafety level-3, which means the scientists must wear hazmat suits and work in sealed rooms.

The experimentation takes the spike protein, the structure on the viral cell that infects humans, from the later variants such as Delta or Omicron, and attaches it to the earlier Wuhuan form.

Black Misandry: SPs on Twitter talking about racism from white clients

Black Misandry: Arab racism

Arab groups have a telegram dedicated to doxxing Arab women who wouldn’t have any issue with dating black men.